Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
As of March 2026 37.71% is owned by Indian Promoters and 62.29% by Public. Top five Promoters holding highest number of shares of Aarey Drugs&Pharma....more...
Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Inside...more...
The Exchange has sought clarification from Aarey Drugs & Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of t...more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Board Comments on the fine levied by the Exchange\r\nmore...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Board Comments on fine levied by the Exchange .more...
The company reported standalone net profit of Rs 0.57 crore for the quarter ended December 31 2025 as compared to Rs 0.72 crore in the same period la...more...
Approval of Unaudited Financial Results for the quarter ended 31st December 2025more...
This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 11th February 2026 have passed the following resoluti...more...
Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to ...more...
As of December 2025 39.05% is owned by Indian Promoters and 60.94% by Public. Top five Promoters holding highest number of shares of Aarey D...more...
Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading...more...
The company reported standalone net profit of Rs 1.02 crore for the quarter ended September 30 2025 as compared to Rs 1.60 crore in the same period l...more...
Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025more...
BOARD MEETINGS Company Name : Aditya Birla Real Date : 06-05-2026